Bank of America upgraded shares of Option Care Health (NASDAQ:OPCH - Free Report) from a neutral rating to a buy rating in a research report sent to investors on Monday, MarketBeat.com reports. Bank of America currently has $33.00 price objective on the stock, up from their prior price objective of $26.00.
A number of other equities analysts have also recently commented on the stock. Truist Financial reduced their price objective on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research report on Friday, November 1st. JMP Securities reiterated a "market outperform" rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday. UBS Group began coverage on Option Care Health in a report on Thursday, December 5th. They set a "neutral" rating and a $26.00 price objective for the company. Jefferies Financial Group downgraded Option Care Health from a "buy" rating to a "hold" rating and decreased their target price for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. Finally, Barrington Research dropped their price target on Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a report on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $29.71.
Check Out Our Latest Analysis on OPCH
Option Care Health Stock Performance
NASDAQ:OPCH traded up $3.73 on Monday, hitting $27.72. The company's stock had a trading volume of 5,927,819 shares, compared to its average volume of 2,115,454. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $4.72 billion, a P/E ratio of 23.29, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. Option Care Health has a one year low of $21.39 and a one year high of $34.63. The stock has a fifty day moving average of $23.10 and a two-hundred day moving average of $27.69.
Insider Buying and Selling
In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm's stock in a transaction on Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is owned by insiders.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of OPCH. UMB Bank n.a. lifted its holdings in shares of Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company's stock worth $26,000 after buying an additional 750 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after acquiring an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its stake in Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock worth $47,000 after acquiring an additional 1,446 shares during the period. International Assets Investment Management LLC increased its position in Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock valued at $91,000 after purchasing an additional 2,757 shares during the period. Finally, Quarry LP raised its holdings in Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock worth $107,000 after purchasing an additional 2,628 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.
About Option Care Health
(
Get Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Recommended Stories
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
